ArticlePharmaceutics2025

Once-Daily Versus Four-Times-Daily Intravenous Busulfan with Therapeutic Drug Monitoring as Conditioning for Hematopoietic Cell Transplantation in Children.

Safaa Bazbaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.